As the discovery of the Alzheimer disease (AD) genes, APP, PSEN1, and PSEN2, in families with autosomal dominant early-onset AD (EOAD), gene discovery in familial EOAD came more or less to a standstill. Only 5% of EOAD patients are carrying a pathogenic mutation in one of the AD genes or a APOE risk allele ε4, most of EOAD patients remain unexplained. Here, we aimed at summarizing the current knowledge of EOAD genetics and its role in ongoing approaches to understand the biology of AD and disease symptomatology as well as developing new therapeutics.
from Dementia Big http://ift.tt/1UlYCGe
via Stopping Dementia
from WordPress http://ift.tt/1MEVSLY
via alcoholic dementia
http://ift.tt/22IIe3J
No comments:
Post a Comment